Microdialysis perfusion of COA-Cl enhances dopamine metabolism in the dorsal striatum of freely moving mice.


Journal

Acta neurobiologiae experimentalis
ISSN: 1689-0035
Titre abrégé: Acta Neurobiol Exp (Wars)
Pays: Poland
ID NLM: 1246675

Informations de publication

Date de publication:
11 Oct 2024
Historique:
received: 01 07 2024
accepted: 06 08 2024
medline: 11 10 2024
pubmed: 11 10 2024
entrez: 11 10 2024
Statut: epublish

Résumé

We performed a microdialysis study to examine the effects of local perfusion of COA‑Cl on the extracellular levels of dopamine (DA) and its metabolites in the dorsal striatum of mice in vivo. The mice were perfused with Ringer's solution (control) and COA‑Cl (0.05, 0.1, or 0.5 mM) into the dorsal striatum. Dialysate samples were collected every 30 min and then analyzed using high‑performance liquid chromatography coupled with an electrochemical detector. We found that local perfusion of COA‑Cl (0.1 or 0.5 mM) into the dorsal striatum of living mice produced a significant and dose‑dependent increase in extracellular levels of DA, 3‑methoxytyramine (3‑MT), and homovanillic acid (HVA), where only 0.5 mM COA‑Cl increased dihydroxyphenylacetic acid (DOPAC) levels. However, 0.05 mM of COA‑Cl did not significantly affect either DA levels or its metabolites. Then, we administered the monoamine oxidase (MAO) inhibitor clorgyline alone or in combination with COA‑Cl (0.1 mM) to test whether COA‑Cl‑induced increases in DOPAC and HVA are mediated by increased MAO activity. Clorgyline alone increased 3‑MT levels and decreased DOPAC and HVA levels but not DA levels. When combined with COA‑Cl, clorgyline increased 3‑MT levels and reversed the decrease in DOPAC and HVA levels caused by clorgyline. The increase in DA metabolism induced by COA‑Cl suggests that some DA was further metabolized into DOPAC, 3‑MT, and HVA. This indicates that COA‑Cl plays a role in DA metabolism via increased DA release and/or activation of MAO, offering new insights into the effects of COA‑Cl on DA metabolism in the brain.

Identifiants

pubmed: 39392021
doi: 10.55782/ane-2024-2585
doi:

Substances chimiques

Dopamine VTD58H1Z2X
Homovanillic Acid X77S6GMS36
3,4-Dihydroxyphenylacetic Acid 102-32-9
Monoamine Oxidase Inhibitors 0
3-methoxytyramine JCH2767EDP
Clorgyline LYJ16FZU9Q
Monoamine Oxidase EC 1.4.3.4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

256-265

Auteurs

Mostofa Jamal (M)

Department of Forensic Medicine, Faculty of Medicine, Kagawa University, Ikenobe, Miki‑cho, Kita‑gun, Japan.

Ikuko Tsukamoto (I)

Department of Pharmaco‑Bio‑Informatics, Faculty of Medicine, Kagawa University, Kagawa, Japan.

Sella Takei (S)

Department of Forensic Medicine, Faculty of Medicine, Kagawa University, Ikenobe, Miki‑cho, Kita‑gun, Japan.

Takanori Miki (T)

Department of Anatomy and Neurobiology, Faculty of Medicine, Kagawa University, Kagawa, Japan.

Hiroshi Kinoshita (H)

Department of Forensic Medicine, Faculty of Medicine, Kagawa University, Ikenobe, Miki‑cho, Kita‑gun, Japan.

Murase Takehiko (M)

Department of Forensic Medicine, Faculty of Medicine, Kagawa University, Ikenobe, Miki‑cho, Kita‑gun, Japan.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH